Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-08-005192
Filing Date
2008-01-28
Accepted
2008-01-28 18:35:27
Documents
1
Period of Report
2007-09-07

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 5449
  Complete submission text file 0001104659-08-005192.txt   7387
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA 1 BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHSEDA MD 20814 3019611992
FINKELSTEIN J J (Reporting) CIK: 0001125610 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-15070 | Film No.: 08555590